Development and Validation of a Liquid Chromatography/Tandem Mass Spectrometry Method for the Quantification of the GLP-1 Analog Semaglutide in Rat Plasma, and Its Application in a Pharmacokinetic Study

  • Kim, Jong-Min; 
  • Kim, Kyoung-Ah; 
  • Yu, Na-Young; 
  • Kim, Dae-Duk; 
  • Kang, Jeong Yeon; 
  • ... Park, Ji-Young; 
  • 외 2명
Citations

WEB OF SCIENCE

2
Citations

SCOPUS

1

초록

Background/Objectives: Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog for type 2 diabetes and obesity, requires sensitive and high-throughput bioanalytical methods to support pharmacokinetic studies. However, previously reported liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays have been limited by lengthy run times (similar to 18 min) and suboptimal sensitivity. This study aimed to develop and validate a rapid, sensitive LC-MS/MS method for quantifying semaglutide in plasma. Methods: Plasma samples (50 mu L) were prepared by acetone-mediated protein precipitation followed by solid-phase extraction. Chromatographic separation was performed on a Cadenza CD-C18 MF column within 9 min, using positive electrospray ionization in multiple reaction monitoring mode with the transitions m/z 1029.4 -> 110.1 for semaglutide and m/z 938.9 -> 109.9 for liraglutide (internal standard). Validation followed the U.S. Food and Drug Administration (FDA) bioanalytical guidelines. Results: The assay showed a lower limit of quantification of 1 ng/mL with linearity across 1-500 ng/mL (R-2 = 0.9999), with sharp peak shape and no carryover. Intra- and inter-day accuracies were 95.69-103.76% and 94.93-100.08%, with precision <= 4.50% and <= 5.88%. Recovery (93.05-107.95%) and matrix effects (96.34-104.12%) were consistent across quality control levels, and the analyte was stable under all tested conditions. The method was successfully applied to a pharmacokinetic study in Sprague-Dawley rats following subcutaneous administration of 50 mu g semaglutide. Conclusions: The validated method offers shorter analysis time, improved sensitivity, and reduced sample volume compared with previously reported assays, supporting its application in preclinical pharmacokinetic studies of semaglutide and related GLP-1 analogs.

키워드

semaglutide; GLP-1; LC-MS/MS; ONCE-WEEKLY SEMAGLUTIDE; OPEN-LABEL; PHASE 3A; ADD-ON; SAFETY; TOLERABILITY; EFFICACY; METFORMIN; 56-WEEK
제목
Development and Validation of a Liquid Chromatography/Tandem Mass Spectrometry Method for the Quantification of the GLP-1 Analog Semaglutide in Rat Plasma, and Its Application in a Pharmacokinetic Study
저자
Kim, Jong-Min; Kim, Kyoung-Ah; Yu, Na-Young; Kim, Dae-Duk; Kang, Jeong Yeon; Baek, Seung-Ki; Park, Jin-Woo; Park, Ji-Young
DOI
10.3390/pharmaceutics18070770
발행일
2026-06-24
유형
Article
저널명
Pharmaceutics
권
18
호
7